In a world where “ageing gracefully” is the new hustle, Monteloeder is banking on brains, literally. Their latest nootropic, Mindrevive, promises to give ageing minds a boost, all thanks to the unlikely hero of the herb garden: sage. Yes, the same stuff you might sprinkle over your roast veggies. But don’t let its culinary roots fool you, paired with Japanese pagoda tree extract, this botanical duo is stepping up as the new dream team for cognitive support.

Source: PFN Ai Archive - Botanicals supporting brain health
The science? A two-phase study that reads like a how-to manual for brain preservation. First, Monteloeder’s lab wizards put nine botanicals through a nootropic obstacle course—testing everything from bilberry to bacopa. Sage (Salvia officinalis), long dismissed as just a kitchen staple, flexed some serious brain-boosting muscle, particularly when it came to reducing oxidative stress and firing up essential growth factors like BDNF (that’s brain-derived neurotrophic factor for the non-nerds).
But it didn’t stop there. Enter Sophora japonica, or Japanese pagoda tree, rich in rutin, an antioxidant powerhouse. When sage and sophora combined forces, the cognitive effects practically doubled. The result? A potent one-two punch against age-related brain fog.
Mindrevive isn’t some vague “feel better” pill.

Clinical trials on 121 adults aged 50–65 with mild cognitive impairment showed real results. After just six weeks, participants saw boosts in short-term memory. By 12 weeks, abstract reasoning and language skills were firing on all cylinders. The higher 400mg dose didn’t just outperform the placebo, it rewired cognitive sharpness faster and more effectively.
Source: ID 282544778 © Nimito | Dreamstime.com
The timing couldn’t be better. With the global nootropics market expected to nearly double to USD4.2 billion by 2033, according to Future Markets Insights, Monteloeder is tapping into a demographic that’s not just ageing but demanding more meaningful, science-backed solutions to stay sharp.
“Cognitive function naturally changes with age,” says Mariana Ortega, Science Marketing Manager at SUANNUTRA, Monteloeder’s parent company. “Mindrevive is designed for older adults who aren’t waiting for cognitive decline—they’re actively fighting it.”
The message is clear - Brain health isn’t a luxury; it’s a necessity. And with consumers chasing functional supplements that actually do something, Monteloeder’s Mindrevive hits the sweet spot of science, simplicity, and, most importantly, results.
Because let’s face it: who wouldn’t want to remember where they left their keys and ace their Sudoku?
ENDS:
Comments